Last reviewed · How we verify
Epinephrin 0.05
Epinephrin 0.05 is a Small molecule drug developed by Kasr El Aini Hospital. It is currently FDA-approved.
At a glance
| Generic name | Epinephrin 0.05 |
|---|---|
| Sponsor | Kasr El Aini Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients (NA)
- Comparison of Milrinone and Epinephrine on TAPSE (NA)
- Photobiomodulation, Er:YAG Laser, and Clobetasol in the Treatment of Oral Lichen Planus. (NA)
- Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal Findings (PHASE4)
- Multimodal Vasopressor Strategy in Septic Shock (PHASE2, PHASE3)
- Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT (NA)
- Epinephrine Nasal Drops for Epistaxis During Nasal Intubation (PHASE2)
- Impact of Perioperative Levosimendan on Patients Undergoing Cardiac Surgery With Low Ejection Fraction (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Epinephrin 0.05 CI brief — competitive landscape report
- Epinephrin 0.05 updates RSS · CI watch RSS
- Kasr El Aini Hospital portfolio CI
Frequently asked questions about Epinephrin 0.05
What is Epinephrin 0.05?
Epinephrin 0.05 is a Small molecule drug developed by Kasr El Aini Hospital.
Who makes Epinephrin 0.05?
Epinephrin 0.05 is developed and marketed by Kasr El Aini Hospital (see full Kasr El Aini Hospital pipeline at /company/kasr-el-aini-hospital).
What development phase is Epinephrin 0.05 in?
Epinephrin 0.05 is FDA-approved (marketed).
Related
- Manufacturer: Kasr El Aini Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing